Opus Genetics
IRD
31 hedge funds and large institutions have $4.56M invested in Opus Genetics in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
11% less funds holding
Funds holding: 35 → 31 (-4)
14% less capital invested
Capital invested by funds: $5.32M → $4.56M (-$757K)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$147K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$32.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.8K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$20.9K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$9.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HVIA
Hudson Valley Investment Advisors
Goshen,
New York
|
-$122K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$109K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$22K |
| 4 |
Goldman Sachs
New York
|
-$10.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $2K | -$1.9K | -7 | -47% |
|
|
WA
27
WFG Advisors
Dallas,
Texas
| $1K | -$815 | -3 | -43% |
|
|
CP
28
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
TWA
30
TCI Wealth Advisors
Tucson,
Arizona
| $1K | – | – | – |
|
|
HVIA
31
Hudson Valley Investment Advisors
Goshen,
New York
| – | -$122K | -417 | Closed |
|
|
BCM
32
Bridgeway Capital Management
Houston,
Texas
| – | -$109K | -375 | Closed |
|
|
33
AQR Capital Management
Greenwich,
Connecticut
| – | -$22K | -77 | Closed |
|
34
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$5K | -17 | Closed |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| – | -$272 | -1 | Closed |
|
IRD Hedge Fund Activity: Q3 2015 in Review
31 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2015, worth a combined $4.56M — down 14% from $5.32M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IRD and 1 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was Renaissance Technologies, adding an estimated $147K. The largest seller was Hudson Valley Investment Advisors, exiting entirely with an estimated $122K sold.
- 31 institutional investors held Opus Genetics (IRD) as of Q3 2015, down from 35 in Q2 2015.
- Funds reported $4.56M of Opus Genetics stock for Q3 2015, down 14% quarter-over-quarter.
- 1 fund opened new Opus Genetics positions in Q3 2015 and 5 closed out, a net change of -4 holders.
- The largest Opus Genetics buyer in Q3 2015 was Renaissance Technologies, an estimated $147K added.
- The largest Opus Genetics seller in Q3 2015 was Hudson Valley Investment Advisors, an estimated $122K sold.
Based on aggregated 13F filings for Q3 2015.